FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087474 [Registered on: 23/05/2025] Trial Registered Prospectively
Last Modified On: 22/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of Crestal Bone Loss Around Dental Implants with and without recombinant human bone morphogenetic protein Coating: A CBCT Study 
Scientific Title of Study   Comparative evaluation of crestal bone loss around dental implant with and without coating of Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2): A Clinico Radiographic CBCT study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Anuradha Mehra 
Designation  Junior Resident 
Affiliation  Subharti Dental College And Hospital 
Address  Subharti Dental College Swami Vivekanand Subharti University
Subharti Puram NH-58, Delhi Haridwar By-Pass Road, Meerut
Meerut
UTTAR PRADESH
250005
India 
Phone  8383062129  
Fax    
Email  anuradhamehra453@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Soundarya Singh 
Designation  Associate Professor 
Affiliation  Surbharti Dental College And Hospital 
Address  Subharti Dental College Swami Vivekanand Subharti University
Subharti Puram NH-58, Delhi Haridwar By Pass Road, Meerut
Meerut
UTTAR PRADESH
250005
India 
Phone  8383062129  
Fax    
Email  singhsoundarya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Anuradha Mehra 
Designation  Junior Resident 
Affiliation  Subharti Dental College And Hospital 
Address  Subharti Dental College Swami Vivekanand Subharti University
Subharti Puram NH-58, Delhi Haridwar BY Pass Road, Meerut
Meerut
UTTAR PRADESH
250005
India 
Phone  8383062129  
Fax    
Email  anuradhamehra453@gmail.com  
 
Source of Monetary or Material Support  
Subharti Dental College And Hospital Swami Vivekanand Subharti University Subharti Puram NH-58, Delhi Haridwar BY Pass Road, Meerut, Uttar Pradesh- 250005, India 
 
Primary Sponsor  
Name  Dr Anuradha Mehra 
Address  Subharti Dental College Swami Vivekanand Subharti University Subharti Puram NH-58, Delhi Haridwar By-Pass Road, Meerut, Uttar Pradesh- 250005, India  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Soundarya Singh  Subharti Dental College And Hospital Swami Vivekanand Subharti University Subharti Puram NH-58, Delhi Haridwar By Pass Road, Meerut  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anuradha Mehra  Subharti Dental College And Hospital  Room No 2 Department Of Periodontology and Implantology NH 58 Delhi Haridwar By Pass Road
Meerut
UTTAR PRADESH 
8383062129

anuradhamehra453@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
University Ethics Committee Medical  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K068||Other specified disorders of gingiva and edentulous alveolar ridge,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Implant only  The Implant will not be coated with rhBMP-2 
Intervention  Implant with rhBMP2  The Implant will be coated with rhBMP-2 at the time of placement. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1. Patients having single missing tooth with an adequate width and height of edentulous space available for placement of implant.
2. Edentulous sites in mandibular and maxillary arches.
3. Adjacent teeth intact; restored with functionally & esthetically good restorations; restored with prosthesis precluding the addition of the missing tooth.
4. Patients with good periodontal and general health.  
 
ExclusionCriteria 
Details  1. Patients who are unable to perform routine oral hygiene procedures.
2. Patients with history of smoking.
3. Patients with TMJ disorders.
4. Patients with dental history of bruxism and parafunctional habits or deep bite cases.
5. History of substance abuse.
6. Insufficient vertical inter arch space to accommodate the prosthodontic components available, together with a proposed pontic and occasional gingival analogue designs.
7. Patients with uncontrolled diabetes.
8. Absence of opposing occlusion.  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Crestal Bone Loss Around Dental Implants  At Baseline 4 Months 9 Months 
 
Secondary Outcome  
Outcome  TimePoints 
Soft Tissue Changes Around The Dental Implant  At Baseline 4 Months 9 Months 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   02/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

In this study we will be randomly selecting 20 patients according to the inclusion and exclusion criteria. 10 patients will be in the test group, where implants will be coated with rhBMP-2 prior to their placement into the osteotomy site. The other 10 patients will be the control group, where the implants will be without the coating of rhBMP-2. At baseline RVG and CBCT will be recorded. The patients will then be re-called after 4 months, and again after 9 months, when the RVG and CBCT will be repeated and the data will be collected. The data of both groups will be statistical analysed for obtaining the final results and drawing conclusions.

 
Close